nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives
|
Lessem, Erica |
|
2015 |
32 |
C |
p. 56-60 5 p. |
artikel |
2 |
Cellular therapy in Tuberculosis
|
Parida, Shreemanta K. |
|
2015 |
32 |
C |
p. 32-38 7 p. |
artikel |
3 |
Commemorating World Tuberculosis Day 2015
|
Zumla, Alimuddin |
|
2015 |
32 |
C |
p. 1-4 4 p. |
artikel |
4 |
Editorial Board
|
|
|
2015 |
32 |
C |
p. i- 1 p. |
artikel |
5 |
Fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems
|
Jabeen, Kauser |
|
2015 |
32 |
C |
p. 118-123 6 p. |
artikel |
6 |
Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment
|
Axelsson-Robertson, Rebecca |
|
2015 |
32 |
C |
p. 23-29 7 p. |
artikel |
7 |
Health status and quality of life in tuberculosis
|
Brown, James |
|
2015 |
32 |
C |
p. 68-75 8 p. |
artikel |
8 |
Host-directed therapies for tuberculous pericarditis
|
Zumla, Alimuddin |
|
2015 |
32 |
C |
p. 30-31 2 p. |
artikel |
9 |
Imaging in tuberculosis
|
Skoura, Evangelia |
|
2015 |
32 |
C |
p. 87-93 7 p. |
artikel |
10 |
Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis
|
Wejse, C. |
|
2015 |
32 |
C |
p. 128-134 7 p. |
artikel |
11 |
Lessons for Tuberculosis from scrutiny of HIV/AIDS and Malaria UK Parliamentary Questions
|
Oliver, Matt |
|
2015 |
32 |
C |
p. 191-195 5 p. |
artikel |
12 |
Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis
|
Axelsson-Robertson, Rebecca |
|
2015 |
32 |
C |
p. 13-22 10 p. |
artikel |
13 |
New tuberculosis diagnostics and rollout
|
McNerney, Ruth |
|
2015 |
32 |
C |
p. 81-86 6 p. |
artikel |
14 |
Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis
|
Bell, Lucy C.K. |
|
2015 |
32 |
C |
p. 39-45 7 p. |
artikel |
15 |
Perspectives on tuberculosis in pregnancy
|
Bates, Matthew |
|
2015 |
32 |
C |
p. 124-127 4 p. |
artikel |
16 |
Regional initiatives to address the challenges of tuberculosis in children: perspectives from the Asia-Pacific region
|
Graham, Stephen M. |
|
2015 |
32 |
C |
p. 166-169 4 p. |
artikel |
17 |
Repurposing—a ray of hope in tackling extensively drug resistance in tuberculosis
|
Maitra, Arundhati |
|
2015 |
32 |
C |
p. 50-55 6 p. |
artikel |
18 |
Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium
|
D’Ambrosio, Lia |
|
2015 |
32 |
C |
p. 156-160 5 p. |
artikel |
19 |
Surgical Treatment of Complications of Pulmonary Tuberculosis, including Drug-Resistant Tuberculosis
|
Madansein, Rajhmun |
|
2015 |
32 |
C |
p. 61-67 7 p. |
artikel |
20 |
Tackling the Tuberculosis Epidemic in sub-Saharan Africa – unique opportunities arising from the second European Developing Countries Clinical Trials Partnership (EDCTP) programme 2015-2024
|
Zumla, Alimuddin |
|
2015 |
32 |
C |
p. 46-49 4 p. |
artikel |
21 |
The complex evolution of antibiotic resistance in Mycobacterium tuberculosis
|
Fonseca, J.D. |
|
2015 |
32 |
C |
p. 94-100 7 p. |
artikel |
22 |
The economic burden of Tuberculosis in Denmark 1998-2010. Cost analysis in patients and their spouses
|
Fløe , Andreas |
|
2015 |
32 |
C |
p. 183-190 8 p. |
artikel |
23 |
The History of Tuberculosis Management in Sweden
|
Wallstedt, Helen |
|
2015 |
32 |
C |
p. 179-182 4 p. |
artikel |
24 |
Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment
|
Sotgiu, Giovanni |
|
2015 |
32 |
C |
p. 101-104 4 p. |
artikel |
25 |
The social context of tuberculosis treatment in urban risk groups in the United Kingdom: a qualitative interview study
|
Craig, Gillian M. |
|
2015 |
32 |
C |
p. 105-110 6 p. |
artikel |
26 |
Tuberculosis among older adults – time to take notice
|
Negin, Joel |
|
2015 |
32 |
C |
p. 135-137 3 p. |
artikel |
27 |
Tuberculosis and chronic respiratory disease: a systematic review
|
Byrne, Anthony L. |
|
2015 |
32 |
C |
p. 138-146 9 p. |
artikel |
28 |
Tuberculosis and HIV co-infection—focus on the Asia-Pacific region
|
Trinh, Q.M. |
|
2015 |
32 |
C |
p. 170-178 9 p. |
artikel |
29 |
Tuberculosis control in prisons: current situation and research gaps
|
Dara, Masoud |
|
2015 |
32 |
C |
p. 111-117 7 p. |
artikel |
30 |
Tuberculosis elimination in the post Millennium Development Goals era
|
Wejse, Christian |
|
2015 |
32 |
C |
p. 152-155 4 p. |
artikel |
31 |
Tuberculosis Vaccines – state of the art, and novel approaches to vaccine development
|
da Costa, Christopher |
|
2015 |
32 |
C |
p. 5-12 8 p. |
artikel |
32 |
Understanding anti-tuberculosis drug efficacy: rethinking bacterial populations and how we model them
|
Evangelopoulos, Dimitrios |
|
2015 |
32 |
C |
p. 76-80 5 p. |
artikel |
33 |
Western Pacific Regional Green Light Committee: progress and way forward
|
Islam, T. |
|
2015 |
32 |
C |
p. 161-165 5 p. |
artikel |
34 |
Why healthcare workers are sick of TB
|
von Delft, Arne |
|
2015 |
32 |
C |
p. 147-151 5 p. |
artikel |